Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

Spherix Incorporated (SPEX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Spherix is an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis. The company is also engaged in providing technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies. Spherix leverages its scientific and technical expertise … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Isis Pharmaceuticals, Inc. (ISIS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Isis Pharmaceuticals is engaged in discovering and developing novel drugs for its product pipeline and for its partners through the exploitation of its leadership position in antisense technology. The company’s pipeline consists of 25 drugs to treat a wide variety … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Verenium Corp. (VRNM) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Verenium Corp. is a leading global industrial biotechnology company engaged in the development and commercialization of high-performance enzymes. The company uses proprietary processes in identifying and evolving enzymes from the broad biodiversity found in nature. Verenium’s tailored enzymes are environmentally … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Wave Systems Corp. (WAVX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Wave Systems Corp. is an industry leader in providing client and server software for hardware-based digital security. The company starts inside the device, thereby reducing the complexity, cost and uncertainty of data protection. Where other vendors try to secure information … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Celsion Corporation (CLSN) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Celsion Corporation is a leading oncology company specializing in the development and commercialization of cancer drugs, including tumor-targeting treatments that utilize focused heat energy combined with heat-activated liposomal drug technology. Celsion has research, license or commercialization agreements with such leading … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Arrowhead Research Corp. (ARWR) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Arrowhead Research is a clinical stage targeted therapeutics company that has development programs in oncology, obesity and infectious disease. The company utilizes its platform technologies in designing and developing peptide-drug conjugates (PDCs), which specifically home to cell types of interest … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Alnylam Pharmaceuticals, Inc. (ALNY) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Alnylam Pharmaceuticals is a biopharmaceutical company engaged in developing novel therapeutics based on RNA interference (RNAi). The company is at the helm of translating RNAi into a new class of innovative medicines, with a core focus on RNAi therapeutics for … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Oculus Innovative Sciences, Inc. (OCLS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Oculus Innovative Sciences is a commercial healthcare company focused on designing, producing and marketing healthcare products that are innovative, safe and effective. The company is engaged in pioneering innovative solutions in multiple markets, including dermatology, surgical, wound care and animal … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Sapiens International Corporation N.V. (SPNS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Sapiens International Corporation is a worldwide provider of innovative insurance software solutions for the financial services industry, offering core, end-to-end software solutions for the general insurance, property, casualty, life, pension and retirement markets. The company has been providing superior software … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

NeoStem, Inc. (NBS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

NeoStem is focused on developing and building on its core capabilities in cell therapy, to capitalize on the burgeoning cell therapy industry as well as cell therapy’s future role in the fight against chronic disease; the company also desires to … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment